George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksOxford Biodyn Share News (OBD)

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.10
Bid: 8.00
Ask: 8.78
Change: 0.00 (0.00%)
Spread: 0.78 (9.75%)
Open: 8.10
High: 0.00
Low: 0.00
Prev. Close: 8.10
OBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: Genus chair buys as shares sink on profit warning

Wed, 24th Nov 2021 16:05

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News:

----------

Kin & Carta PLC - London-based business consultancy - Marie James Capital LLC, a holding company managed by Chief Executive Officer John Schwan on behalf of his children's estate, sells 5 million shares, a 2.9% stake, via an accelerated bookbuild run by Numis Securities Ltd and Peel Hunt LLP, Numis confirms on Wednesday. The sale at 301 pence is worth GBP15.1 million. Schwan's investment vehicle continues to hold a 1.5% stake in Kin & Carta, and this is subject to a 12-month lock-up. Additionally, he directly holds 8.0 million shares, a 4.6% stake, according to Morningstar.

----------

LondonMetric Property PLC - invests in distribution and long-income properties across UK - Non-Executive Chair Patrick Vaughan sells 400,000 shares at 271p, worth GBP1.1 million, on Tuesday. Retains 10.3 million shares.

----------

Genus PLC - Basingstoke, Hampshire-based biotechnology products for cattle and pig farmers - Chair Iain Ferguson and wife Catherine buy 5,000 shares at average 4,476.5 pence and 4,495.6p, worth GBP224,016, on Wednesday. Shares in Genus sink more than 10% on Wednesday after the firm reports difficulties in the Chinese pig market. Ferguson, the former chief executive of sweeteners and food ingredients firm Tate & Lyle PLC, took the Genus chair in July 2020.

----------

Aston Martin Lagonda Global Holdings PLC - Warwick-based luxury carmaker - Non-Executive Director Anne Stevens buys 7,000 shares at GBP15.81, worth GBP110,670, on Tuesday.

----------

Oxford BioDynamics PLC - biotechnology firm focused on discovery and development of epigenetic biomarkers - Non-Executive Director Stephen Diggle buys 100,000 shares via Vulpes Life Sciences Fund at 41.2 pence, worth GBP41,200, on Tuesday. Diggle had bought 198,004 shares on Thursday and Friday last week and 2.5 million shares on Tuesday last week. Diggle now is interested in 15.0 million shares, a 15% stake.

----------

EnQuest PLC - oil and gas production in UK North Sea and Malaysia - Chief Executive Amjad Bseisu buys 434,145 shares via investment vehicle Double A Ltd at GBP0.19, worth GBP82,488, on Tuesday.

----------

Carclo PLC - West Yorkshire-based plastic parts manufacturer - Executive Chair Nick Sanders buys 127,219 shares at 38.95p, worth GBP49,552, on Tuesday.

----------

Dunedin Enterprise Investment Trust PLC - investor in UK mid-market management buyouts - Director Angela Lane sells 11,445 shares at GBP5.24, worth GBP59,953, on Thursday last week, as part of trust's tender offer.

----------

Record PLC - Windsor, Berkshire-based currency and derivatives manager - Non-Executive Director Krystyna Nowak buys 29,500 shares at GBP0.83, worth GBP24,574, on Wednesday.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
17 Dec 2021 20:34

IN BRIEF: Oxford BioDynamics Covid severity tests available in US

IN BRIEF: Oxford BioDynamics Covid severity tests available in US

Read more
22 Nov 2021 16:54

DIRECTOR DEALINGS: Croda general counsel sells GBP200,000 in shares

DIRECTOR DEALINGS: Croda general counsel sells GBP200,000 in shares

Read more
18 Nov 2021 16:20

IN BRIEF: Oxford BioDynamics director Diggle raises stake to 15%

IN BRIEF: Oxford BioDynamics director Diggle raises stake to 15%

Read more
25 Oct 2021 17:53

TRADING UPDATES: Ridgecrest ends Blue Air deal; Vast's Baita Plai hit

TRADING UPDATES: Ridgecrest ends Blue Air deal; Vast's Baita Plai hit

Read more
31 Aug 2021 21:35

TRADING UPDATES: Jet2 in bumper Airbus order; Strix China factory live

TRADING UPDATES: Jet2 in bumper Airbus order; Strix China factory live

Read more
31 Aug 2021 12:48

Oxford BioDynamics awarded $0.91m US PACT grant

(Sharecast News) - Oxford BioDynamics has been awarded an FNIH Partnership for Accelerating Cancer Therapies (PACT) grant, it announced on Tuesday, to use its 'EpiSwitch' diagnostic platform for the accurate prediction of a patient's response to immune checkpoint inhibitors (ICIs) from a routine blood sample.

Read more
15 Jun 2021 14:42

TRADING UPDATES: GB Group rebuilds dividend; IPF ups 2021 profit view

TRADING UPDATES: GB Group rebuilds dividend; IPF ups 2021 profit view

Read more
8 Jun 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
9 Apr 2021 12:44

Oxford BioDynamics "significantly" expands UK facilities with new lab

Oxford BioDynamics "significantly" expands UK facilities with new lab

Read more
31 Mar 2021 21:18

IN BRIEF: Oxford BioDynamics inks EpiSwitch kit deal with Agilent

IN BRIEF: Oxford BioDynamics inks EpiSwitch kit deal with Agilent

Read more
31 Mar 2021 08:05

Oxford Biodynamics inks agreement with Agilent Technologies for EpiSwitch kit

(Sharecast News) - Biotechnology company Oxford BioDynamics has signed a supply and resale agreement with US firm Agilent Technologies for the manufacture and sale of its new EpiSwitch Explorer Array Kit.

Read more
23 Mar 2021 11:24

AIM WINNERS & LOSERS: Time Out ditches Waterloo market, plans raise

AIM WINNERS & LOSERS: Time Out ditches Waterloo market, plans raise

Read more
23 Mar 2021 11:17

IN BRIEF: Oxford BioDynamics launches Covid-19 severity test in US

IN BRIEF: Oxford BioDynamics launches Covid-19 severity test in US

Read more
17 Mar 2021 16:31

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.